Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nuffel EV"'
Autor:
Hanckmann E; Byondis B.V., Bioanalysis & Protein Interaction department, Microweg 22, 6545CM, Nijmegen, The Netherlands., Heads P; Orion Corporation, Translational Bioanalytics, Biomarkers & Biotransformation, Orionintie 1, FI-02200, Espoo, Finland., Pineault K; UCB Biopharma SRL, Translational Biomarker & Bioanalysis, Chemin du Foriest 1, 1420 Braine-l'Alleud, Belgium., Szuster C; Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, UK., Zeiser K; Nuvisan GmbH, Bioanalysis - Immunoassays, Wegenerstrasse 13, 89231, Neu-Ulm, Germany., Beecroft J; Roche Pharma Research & Early Development (pRED) Pharmaceutical Sciences BioX Regulated Bioanalysis & Biosample Operations Roche Innovation Center, 4070, Basel, Switzerland., Da Cunha MC; Intertek Pharmaceutical Services, Bioanalytical, Immunoassay - Hexagon Tower, M9 8GQ, Manchester, UK., Dan B; Roche Pharma Research & Early Development (pRED) Pharmaceutical Sciences BioX Regulated Bioanalysis & Biosample Operations Roche Innovation Center, 4070, Basel, Switzerland., Heughebaert L; Ghent University, Laboratory of Toxicology, 9000, Ghent, Belgium., Hogan D; Charles River Laboratories Edinburgh Ltd, Department of Immunology, Bioanalysis & Biomarkers Edinburgh, EH14 4AS, UK., Jacobs C; Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany., Schaar JM; Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany., Marincich L; Department for Life Quality Studies (QuVi), Alma Mater Studiorum - University of Bologna, Rimini Campus, Corso d'Augusto 237, 47921, Rimini, Italy., Minelli F; Merck KGaA, R&D, New Biological Entities Drug Metabolism Pharmacokinetics, Innovative BioAnalytics, 10010, Colleretto Giacosa (TO), Italy., Noor B; AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, Cambridge, CB21 6GH, UK., Reille-Seroussi M; Sanofi-Aventis Deutschland GmbH, Bioanalysis & Immunogenicity, DMPK, Industriepark Höchst, 65926, Frankfurt am Main, Germany., Roberts A; Quotient Sciences, Bioanalytical Services, NE66 2DH, Alnwick, UK., Seavers L; Labcorp Early Development Laboratories Ltd., Immunology & Immunotoxicology, Huntingdon, PE28 4HS, UK., Spendal M; Novo Nordisk A/S, Non-clinical & Clinical Assay Sciences, Global Discovery & Development Sciences, Global Drug Discovery, DK-2760, Maaløv, Denmark., Thomas H; Pharmaron, Metabolism, Pegasus Way, Crown Business Park, Rushden, NN10 6ER, UK, employed by GSK, IVIVT-BIB, Gunnells Wood Road, SG1 2NY, Stevenage, UK during the meeting., Klooster JV; ICON Bioanalytical Laboratories, Amerikaweg 18, 9407 TK, Assen, The Netherlands., Nuffel EV; Sanofi, Bioanalysis & Immunogenicity, DMPK, 9052, Zwijnaarde, Belgium., Wolter L; AbbVie Deutschland GmbH & Co. KG, Quantitative, Translational & ADME Sciences, Knollstraße, 67061, Ludwigshafen (Rhein), Germany., Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, 1000, Brussels, Belgium.
Publikováno v:
Bioanalysis [Bioanalysis] 2024; Vol. 16 (12), pp. 569-574. Date of Electronic Publication: 2024 May 09.
Autor:
Heughebaert L; Laboratory of Toxicology, Ghent University, Ghent, 9000, Belgium., Williams A; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, United Kingdom., Roberts A; Bioanalytical Services, Quotient Sciences, Alnwick, NE66 2DH, United Kingdom., Jacobs C; Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, 66421, Germany., Szuster C; LC-MS Bioanalysis, Drug Development Solutions (part of Alliance Pharma), Fordham, CB7 5WW, United Kingdom., Walker C; Roche Innovation Center Welwyn (contractor), Welwyn Garden City, Hertfordshire, AL7 1TW, United Kingdom (employed by Quotient Sciences, Alnwick, NE66 2DH, United Kingdom, during the meeting)., Nuffel EV; Bioanalysis & Immunogenicity, DMPK, Sanofi, Zwijnaarde, 9052, Belgium., Atkin E; Bioanalytical Services, ACM Global Laboratories, York, YO10 4DZ, United Kingdom., Minelli F; R&D, New Biological Entities Drug Metabolism Pharmacokinetics, Innovative BioAnalytics, Merck KGaA, Colleretto Giacosa (TO), 10010, Italy., Groves K; Translational Biomarker & Bioanalysis, UCB Biopharma SRL, Chemin du Foriest 1, Braine-l'Alleud, 1420, Belgium., Sime K; Charles River Laboratories Edinburgh Ltd, Clearwater House, Research Avenue South, Edinburgh, EH14 4AS, United Kingdom., Zeiser K; Bioanalysis, Nuvisan GmbH, Neu-Ulm, 89231, Germany., Protti M; Research Group of Pharmaco-Toxicological Analysis (PTA Lab), Department of Pharmacy & Biotechnology (FaBiT), Alma Mater Studiorum, University of Bologna, Bologna, 40127, Italy., Wagmann L; Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, 66421, Germany., Knight O; Intertek Pharmaceutical Services, Manchester, M9 8GQ, United Kingdom., Stewart R; Discovery Bioanalysis, Labcorp Early Development Laboratories Ltd, Harrogate, HG3 1PY, United Kingdom., Penford R; Bioanalysis, Immunogenicity & Biomarkers, GSK, Stevenage, SG1 2NY, United Kingdom., Calogero S; Biochemical Analysis, Swiss BioQuant, Reinach (BL), 4153, Switzerland (employed by F. Hoffmann-La Roche Ltd, Bioanalytical R&D, Regulated Bioanalysis, Basel, 4070, Switzerland, during the meeting)., Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, Brussels, 1000, Belgium.
Publikováno v:
Bioanalysis [Bioanalysis] 2022 Dec; Vol. 14 (23), pp. 1471-1477. Date of Electronic Publication: 2023 Feb 03.